Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1-2 study of an investigational antitumor agent with paclitaxel in Japan
jRCT2080223902Phase 2Terminated
- Start
- May 2018
- Modality
- Small Molecules
01
Overview
Phase 2 trial of paclitaxel in cancer (2 arms). Started May 2018; status: terminated.
02
Drugs
paclitaxel
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080223902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223902.